PubMed · 1985 · 21 citations · 6 references
PharmacyInfectious DiseasesPharmacotherapyAntimicrobial PharmacotherapyInfectious Disease PharmacotherapyParasitologyAntiparasitic AgentsAntiparasitic PharmacotherapyAntiparasitic TherapyClinical ParasitologyMalariaMedical ParasitologyAbdominal DiscomfortAntimalarial Drug CombinationsChemotherapy Of MalariaDouble-blind TrialsPlasmodium FalciparumTreatment Of Malaria
Fansimef is a combination of 250 mg of mefloquine, 500 mg of sulfadoxine, and 25 mg of pyrimethamine per tablet. A total of 150 adult male Zambian patients who had symptomatic Plasmodium falciparum parasitaemia were treated in a double-blind randomized fashion with either one, two or three tablets of Fansimef. All patients in the three treatment groups showed an S-type response. The rates of clearance of parasitaemia and fever were similar in all treatment groups. Tolerance was good at all dose levels. The main side-effects were abdominal discomfort, weakness and lassitude, dizziness, and pruritus, but these were mild, transient and required no specific treatment. Vomiting occurred only in 4% of patients given the highest dose of three tablets. The results of various haematological and biochemical investigations and urinalysis were not adversely altered by the administration of Fansimef.
6
Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine.
E. B. Doberstyn, P Phintuyothin, S. Noeypatimanondh et al. · PubMed · 1979 · 73 citations